We use first-party cookies to provide you the best possible experience. Necessary By clicking "Accept", you agree to the use of our cookies on your device. By clicking "Decline", you can continue Browse but certain features may be limited.

World'sLargestAI-PoweredTherapeuticAssetAccelerator

Partex.AI is solving the inefficiency problem in Drug Discovery & Development using Big Data & Artificial Intelligence

Opportunity

Over 18,000 drugs in clinical development globally, with 8,000 in the U.S. - only ~50 drugs approved by FDA

In-licensing or out-licensing takes over 3 years, consuming more than 25% drug patent life

Global pharma market $1.3Tn growing at 6% CAGR. A $300Bn patent cliff looms, with 6 of top 10 oncology drugs losing exclusivity within next 4 years

"Unlocking a $50Bn opportunity for AI in drug discovery and development"

What We Do

With unrivalled computing power, a multi-disciplinary team, and life science data, Partex.AI supports the healthcare industry to identify drugs faster, cost effective and for the right patients. Validated by wet-lab and Real-World Data, AI at Scale is unlocking hidden value in already discovered therapeutic assets.

Therapeutics

Identifying late stage preclinical - early clinical drug assets with strong scientific foundations but suboptimal development paths, Partex.AI proprietary models optimize towards key value inflection. Currently incubating three promising drug assets in oncology within our SPV

Exchange

Pharma and biotech partnerships with Partex.AI, unlock value from deprioritized or off-strategy drug assets through AI-driven in- and out-licensing. By data-enabling asset evaluation and repositioning, we facilitate efficient pipeline optimization through adaptable, value-based collaboration models

Coming Soon

We're preparing something amazing for our Exchange section. Stay tuned!

Labs

Driving the future of AI-powered drug discovery. We specialize in developing next-generation functional assays and high-throughput experimental screening to rigorously test and confirm AI-driven predictions. By integrating advanced computational modeling with hands-on laboratory science in disease-relevant systems, we create a seamless, closed-loop model - delivering tangible, experimental evidence validating the AI

Real-World Data

Driving innovation and transforming healthcare through equitable and trustworthy Real-World Data — built on scalable global partnerships with healthcare providers improving patient outcomes

How We Do It

We don't just discover drugs

We manage their future

Talk to us to explore licensing, partnerships, or how AI can reshape your drug pipeline